Rapid diagnosis and characterization of acute promyelocytic leukaemia in routine laboratory practice

Clinical and Laboratory Haematology

Volumn 26, Issue 2, 2004, Pages 101-106

  Lock, R J ^a   Virgo, P F ^a   Kitchen, C ^a   Evely, R S ^b  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

Author keywords

Acute promyelocytic leukaemia; Immunophenotyping; Myeloperoxidase; PML protein; t(15; 17)(q22; 21)

Indexed keywords

MYELOPEROXIDASE;

ADULT; ARTICLE; BLAST CELL; BONE MARROW CELL; CELL STRUCTURE; CHILD; CHROMOSOME 15; CHROMOSOME 17; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FEMALE; HUMAN; IMMUNOPHENOTYPING; LABORATORY TEST; MALE; MEDICAL PRACTICE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION;

ADULT; ANTIGENS, CD; ANTIGENS, CD13; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BONE MARROW; CHILD; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, PROMYELOCYTIC, ACUTE; LYMPHOCYTES; MALE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PEROXIDASE; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 1942442136     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2004.00593.x     Document Type: Article

References (23)

1. d'Onofrio G. (2001) PANDA - innovative classification of hematopoietic malignacies. Bloodline Reviews 1(2-R), 3-6.
2. Allford S., Grimwade D., Langabeer S., Duprez E., Saurin A., Chatters S., Walker H., Roberts P., Rogers J., Bain B., Patterson K., McKernan A., Freemont P., Solomon E., Burnett A., Goldstone A. & Linch D. (1999) Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARα. rearrangement in newly diagnosed AML. British Journal of Haematology 105, 198-207.
3. Bain B.J., Barnett D., Linch D., Matutes E. & Reilly J.T. (2002) Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders. Clinical and Laboratory Haematology 24, 1-13.
4. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R. & Sultan C. (1976) Proposals for the classification of acute leukemias. French-American-British (FAB) Co-operative Group. British Journal of Haematology 33, 451-458.
5. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R. & Sultan C. (1985) Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American- British Cooperative Group. Annals of Internal Medicine 103, 620-625.
6. Chen Z., Guidez F., Rousselot P., Agadir A., Chen S.J., Wang Z.Y., Degos L., Zelent A., Waxman S. & Chomienne C. (1993) PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. Journal of Clinical Investigation 91, 2260-2267.
7. Czepulkowski B. (2001) Basic techniques for the preparation and analysis of chromosomes from bone marrow and leukaemic blood. In: Human Cytogenetics Malignancy and Acquired Abnormalities (ed. D.E. Rooney), 3rd edn, Chapter 1. pp. 1-26. Oxford University Press, Oxford, UK.
8. Falini B., Flenghi L., Fagioli M., Lo Coco F., Cordone I., Diverio D., Pasqualucci L., Biondi A., Riganelli D., Orleth A., Liso A., Martelli M.F., Pelicci P.-G. & Pileri S. (1997) Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). Blood 90, 4046-4053.
9. Grimwade D., Biondi A., Mozziconacci M.-J., Hagemeijer A., Berger R., Neat M., Howe K., Daslugue N., Jansen J., Radford-Weiss I., Lo Coco F., Lessard M., Hernandez J.-M., Delabesse E., Head D., Liso V., Sainty D., Flandrin G., Solomon E., Birg F. & Lafage-Pochilaloff M. (2000) Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Blood 96, 1297-1308.
10. Groenveld K., te Marvelde J.G., van den Beemd M.W., Hooijkaas H. & van Dongen J.J. (1996) Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes. Leukemia 10, 1383-1389.
11. Hrušák O. & Porwit-MacDonald A. (2002) Antigen expression patterns reflecting genotype of acute leukemias. Leukemia 16, 1233-1258.
12. Lee D.S., Lee Y.S., Kim Y.R., Han K.S., Park K.U., She C.J., Kim B.C., Park S.Y. & Cho H.I. (2002) RARA fluorescence in in situ hybridization overcomes the drawback of PML/RARA fluorescence in situ hybridization in follow-up of acute promyelocytic leukemia. Cancer Genetics and Cytogenetics 139, 104-108.
13. Licht J.D., Chomienne C., Goy A., Chen A., Scott A.A., Head D.R., Michaux J.L., Wu Y., DeBlasio A., Miller W.H. Jr. Zelenetz A.D., Willman C.L., Chen Z., Chen S.-J., Zelent A., Macintyre E., Veil A., Cortes J., Kantargian H. & Waxman S. (1995) Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood 85, 1083-1094.
14. Lo Coco F., Avvisati G., Diverio D., Biondi A., Pandolfi P.P., Alcalay M., De Rossi G., Petti M.C., Cantu-Rajnoldi A., Pasqualetti D., Nanni M., Fenu S., Frontani M. & Madelli F. (1991) Rearrangements of the RAR-alpha gene in acute promyelocytic leukaemia: correlations with morphology and immunophenotype. British Journal of Haematology 78, 494-499.
15. Miller W.H. Jr, Kakizuka A., Frankel S.R., Warrell R.P. Jr., DeBlasio A., Levine K., Evans R.M. & Dmitrovsky E. (1992) Reverse transcription polymerase chain reaction for the rear-ranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 89, 2694-2698.
16. O'Connor S.J., Forsyth P.D., Dalal S., Evans P.A., Short M.A., Schiach C., Jack A.S. & Morgan G.J. (1997) The rapid diagnosis of acute promyelocytic leukaemia using PML (5E10) monoclonal antibody. British Journal of Haematology 99, 597-604.
17. Orfao A., Chillón M.C., Bortoluci A.M., López-Berges M.C., García-Sanz R., Gonzales M., Tabernero M.D.. García-Marcos M.A., Rasillo A.I., Hernández-Rivas J. & San Miguel J.F. (1999) The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARα gene rearrangements. Haematologica 84, 405-412.
18. Paietta E., Andersen J., Gallagher R., Bennett J., Yunis J., Cassileth P., Rowe J. & Wiernik P.H. (1994) The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study. Leukemia 8, 1108-1112.
19. Sanz M.A., Martín G. & Díaz-Mediavilla J. (1997) All-trans-retinoic acid in acute promyelocytic leukemia [letter]. New England Journal of Medicine 338, 393-394.
20. Tallman M.S., Andersen J.W., Schiffer C.A., Appelbaum F.R., Feusner J.H., Ogden A., Shepherd L., Willman C., Bloomfield C.D., Rowe J.M. & Wiernik P.H. (1997) All-trans-retinoic acid in acute promyelocytic leukemia. New England Journal of Medicine 337, 1021-1028.
21. Vardiman J.W., Harris N.L. & Brunning R.D. (2002) The World Health Organization (WHO) classification of myeloid neoplasms. Blood 100, 2292-2302.
22. Wells R.A., Catzavelos C. & Kamel-Reid S. (1997) Fusion of retinoic acid receptor α to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia. Nature Genetics 17, 109-113.
23. Wheatley K., Burnett A.K., Goldstone A.H., Gray R.G., Hann I.M., Harrison C.J., Rees J.H.K., Stevens R.F. & Walker H. (1999) A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. British Journal of Haematology 107, 69-79.